Skip to main content
. Author manuscript; available in PMC: 2008 Jul 1.
Published in final edited form as: Schizophr Res. 2007 Apr 16;93(1-3):304–316. doi: 10.1016/j.schres.2007.03.001

Table 2.

Characteristics of sample in Experiment 2

Low ThD Patients
n=11
High ThD Patients
n=10
M SD M SD
Age (years) 33.64 6.78 31.60 8.33
WAIS-R IQ 97.91 15.63 91.20 8.99
WRAT-R IQ 105.64 11.74 106.30 10.24
BPRS^ 32 (range 20-46) 7.67 40 (range 19-62) 15.02
Neuroleptic medication 9 5
-clozapine/olanzapine 4 5
- risperidone 5 0
- high potency drug*** 0 1
- anticholinergics 4 0
- adjunctives**** 5 4
TLC scores N/A
 - global # 1.30 (range 0-1.75) 0.53 2.75 (range 2-3.75) 0.59
 - poverty of speech 0.64 (range 0-2) 0.81 1.00 (range 0-3) 1.07

Patient groups were matched on age (p>.5), WRAT-R (p>.5) and WAIS-R (p>.1). There were twenty-four healthy control participants (11 females, 13 males) mean age 31.17 years (SD=9.34). Their mean score on the WRAT-R was 109.36 (SD=11.47) and on the WAIS-R was 111.65 (SD=13.21).

***

= haloperidol

****

=lithium, depakote, sertraline, lorazepam, venlafaxine, clonazepam, buspirone

^

The Brief Psychiatric Rating Scale (Overall & Gorham, 1962) – total score exclusive of conceptual disorganization.

No differences between the Cohorts #1 and #2 patient groups (Tables 1 and 2 respectively) on global TLC scores (using a scale of 0-4), p>.05.